<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 25 Jun 2026 07:06:54 -0400--><rss version="2.0">
    <channel>
        <title>Acurx Pharmaceuticals, Inc. (ACXP) SEC Filings</title>
        <link>https://ir.acurxpharma.com/all-sec-filings/rss</link>
        <description>Acurx Pharmaceuticals, Inc. (ACXP) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_e3699250203878e4a2aa0be38dc8c3f2/acurxpharma/logo.png</url>
                <title>Acurx Pharmaceuticals, Inc. Logo</title>
                <link>https://ir.acurxpharma.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[EFFECT - Notice of Effectiveness]]></title>
                <description><![CDATA[EFFECT]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-525-9999999995-26-001578</link>
                <pubDate>Tue, 12 May 26 06:07:09 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-525-9999999995-26-001578</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[EFFECT - Notice of Effectiveness]]></title>
                <description><![CDATA[EFFECT]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-524-9999999995-26-001577</link>
                <pubDate>Tue, 12 May 26 06:07:01 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-524-9999999995-26-001577</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]></title>
                <description><![CDATA[424B3]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-527-0001104659-26-059298</link>
                <pubDate>Tue, 12 May 26 15:05:23 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-527-0001104659-26-059298</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]></title>
                <description><![CDATA[424B3]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-526-0001104659-26-059296</link>
                <pubDate>Tue, 12 May 26 15:04:32 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-526-0001104659-26-059296</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-519-0001104659-26-058631</link>
                <pubDate>Mon, 11 May 26 16:12:03 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-519-0001104659-26-058631</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[CORRESP - Correspondence]]></title>
                <description><![CDATA[CORRESP]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-536-0001104659-26-057279</link>
                <pubDate>Tue, 09 Jun 26 12:50:40 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-536-0001104659-26-057279</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[CORRESP - Correspondence]]></title>
                <description><![CDATA[CORRESP]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-535-0001104659-26-057277</link>
                <pubDate>Tue, 09 Jun 26 12:50:38 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-535-0001104659-26-057277</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[UPLOAD - SEC-generated letter]]></title>
                <description><![CDATA[2 Related Documents: LETTER, TEXT-EXTRACT]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-533-0000000000-26-004693</link>
                <pubDate>Tue, 09 Jun 26 12:50:36 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-533-0000000000-26-004693</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[UPLOAD - SEC-generated letter]]></title>
                <description><![CDATA[2 Related Documents: LETTER, TEXT-EXTRACT]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-531-0000000000-26-004692</link>
                <pubDate>Tue, 09 Jun 26 12:50:35 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-531-0000000000-26-004692</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]></title>
                <description><![CDATA[4 Related Documents: S-1, EX-5.1, EX-23.1, EX-FILING FEES]]></description>
                <link>https://ir.acurxpharma.com/all-sec-filings?page=1#document-515-0001104659-26-054887</link>
                <pubDate>Mon, 04 May 26 16:13:05 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/all-sec-filings?page=1#document-515-0001104659-26-054887</guid>
                                                                            </item>
            </channel>
</rss>